Covid-19: Cytokine storm and Coagulopathy biomarkers, IL-6 and D-Dimer, well managed with Nichi-Glucan REFIX in clinical study: https://www.medrxiv.org/content/10.1101/2021.08.09.21261738v1

Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster in 6th Microbiome Asia Conference in Tokyo 26~27 April 2023
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster